Gastric Motility Disorder – Pipeline Review, H2 2012

Publisher Name :
Date:31-Oct-2012
No. of pages: 40
Inquire Before Buying

Gastric Motility Disorder – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Gastric Motility Disorder – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Gastric Motility Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastric Motility Disorder. Gastric Motility Disorder – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Gastric Motility Disorder.
- A review of the Gastric Motility Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Gastric Motility Disorder pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Gastric Motility Disorder.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Gastric Motility Disorder pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Gastric Motility Disorder – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gastric Motility Disorder Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Gastric Motility Disorder 7
Gastric Motility Disorder Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Gastric Motility Disorder Therapeutics - Products under Development by Companies 14
Companies Involved in Gastric Motility Disorder Therapeutics Development 15
Theravance, Inc. 15
Helsinn Healthcare S.A. 16
Tranzyme Pharma, Inc. 17
Concert Pharmaceuticals, Inc. 18
Elixir Pharmaceuticals, Inc. 19
Gastric Motility Disorder - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
ulimorelin hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
TZP-102 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
EX-1314 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
velusetrag - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ipamorelin - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
TD-8954 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34
Gastric Motility Disorder - Product Development Milestones 38
Featured News & Press Releases 38
Jun 06, 2012: Tranzyme To Present Data On TZP-102 At American Diabetes Association Scientific Sessions 38
Jun 01, 2012: RaQualia Pharma Initiates First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Feb 29, 2012: RaQualia Pharma Receives MHRA Approval To Initiate First-In-Human Study For 5-HT4 Partial Agonist RQ-00000010 38
Appendix 39
Methodology 39
Coverage 39
Secondary Research 39
Primary Research 39
Expert Panel Validation 39
Contact Us 40
Disclaimer 40

List of Tables
Number of Products Under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Comparative Analysis by Late Stage Development, H2 2012 10
Comparative Analysis by Mid Clinical Stage Development, H2 2012 11
Comparative Analysis by Early Clinical Stage Development, H2 2012 12
Comparative Analysis by Pre-Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Theravance, Inc., H2 2012 15
Helsinn Healthcare S.A., H2 2012 16
Tranzyme Pharma, Inc., H2 2012 17
Concert Pharmaceuticals, Inc., H2 2012 18
Elixir Pharmaceuticals, Inc., H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Gastric Motility Disorder Therapeutics - Drug Profile Updates 34

List of Figures
Number of Products under Development for Gastric Motility Disorder, H2 2012 7
Products under Development for Gastric Motility Disorder - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Late Stage Products, H2 2012 10
Mid Clinical Stage Products, H2 2012 11
Early Clinical Stage Products, H2 2012 12
Pre-Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H1 2014
    Published: 25-Jun-2014        Price: US $2000 Onwards        Pages: 126
    Global Markets Direct's, ‘Adenocarcinoma Of The Gastroesophageal Junction Pipeline Review, H1 2014', provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Adenocarcinoma Of The Gastroesophageal Junction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ......
  • Emesis (Vomiting) – Pipeline Review, H1 2014
    Published: 25-Jun-2014        Price: US $2000 Onwards        Pages: 61
    Global Markets Direct's, ‘Emesis (Vomiting) Pipeline Review, H1 2014', provides an overview of the Emesis (Vomiting)'s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Emesis (Vomiting), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key......
  • Gastric Ulcers – Pipeline Review, H1 2014
    Published: 15-Jun-2014        Price: US $2000 Onwards        Pages: 48
    Global Markets Direct's, ‘Gastric Ulcers Pipeline Review, H1 2014', provides an overview of the Gastric Ulcers's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players ......
  • Global and Chinese Sucralfate (CAS 54182-58-0) Industry, 2009-2019 Market Research Report
    Published: 14-Jun-2014        Price: US $2400 Onwards        Pages: 150
    Global and Chinese Sucralfate (CAS 54182-58-0) Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Sucralfate (CAS 54182-58-0) industry. The report firstly reviews the basic information of Sucralfate (CAS 54182-58-0) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Sucralfate (CAS 54182-58-0) listing their product specification, capacity, production va......
  • Global and Chinese Proglumide (CAS 6620-60-6) Industry, 2009-2019 Market Research Report
    Published: 14-Jun-2014        Price: US $2400 Onwards        Pages: 150
    Global and Chinese Proglumide (CAS 6620-60-6) Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Proglumide (CAS 6620-60-6) industry. The report firstly reviews the basic information of Proglumide (CAS 6620-60-6) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Proglumide (CAS 6620-60-6) listing their product specification, capacity, production value,......
  • Global and Chinese Famotidine (CAS 76824-35-6) Industry, 2009-2019 Market Research Report
    Published: 14-Jun-2014        Price: US $2400 Onwards        Pages: 150
    Global and Chinese Famotidine (CAS 76824-35-6) Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Famotidine (CAS 76824-35-6) industry. The report firstly reviews the basic information of Famotidine (CAS 76824-35-6) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Famotidine (CAS 76824-35-6) listing their product specification, capacity, production va......
  • Digestive Remedies Markets in China
    Published: 1-Jun-2014        Price: US $4000 Onwards        Pages: 192
    China's demand for Digestive Remedies has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.......
  • Enterocolitis – Pipeline Review, H1 2014
    Published: 15-May-2014        Price: US $2000 Onwards        Pages: 42
    Global Markets Direct's, ‘Enterocolitis Pipeline Review, H1 2014', provides an overview of the Enterocolitis's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Enterocolitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players inv......
  • Market Research Report on Global and Chinese Cimetidine(CAS 38585-62-5) Industry, 2009-2019
    Published: 3-May-2014        Price: US $2400 Onwards        Pages: 150
    Market Research Report on Global and Chinese Cimetidine(CAS 38585-62-5) Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Cimetidine(CAS 38585-62-5) industry. The report firstly reviews the basic information of Cimetidine(CAS 38585-62-5) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Cimetidine(CAS 38585-62-5) listing their product specification, capacity, Production val......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs